Showing results (4011-4020 of 6,795) with videos related to
Sort By:
Pageof 680
Clinical Therapeutics|April 28, 2009
Efficacy and safety of low-dose transdermal buprenorphine patches (5, 10, and 20 microg/h) versus prolonged-release tramadol tablets (75, 100, 150, and 200 mg) in patients with chronic osteoarthritis pain: a 12-week, randomized, open-label, controlled, parallel-group noninferiority studyMats Karlsson, Anna-Carin BerggrenClinical Therapeutics|April 28, 2009
Topiramate versus amitriptyline in migraine prevention: a 26-week, multicenter, randomized, double-blind, double-dummy, parallel-group noninferiority trial in adult migraineursDavid W Dodick, Fred Freitag, James Banks, et al.Clinical Therapeutics|April 28, 2009
Effects of pitavastatin on cerebral blood flowYoshihiko Horimoto, Michitaka Matsubara, Hirokazu Mizutani, et al.Clinical Therapeutics|April 28, 2009
Drug rash with eosinophilia and systemic signs syndrome in a patient with multiple sclerosisAngelo Caruso, Rosario Vecchio, Francesco Patti, et al.Clinical Therapeutics|April 28, 2009
A single-dose, randomized, two-way crossover study comparing two olanzapine tablet products in healthy adult male volunteers under fasting conditionsAhmed H Elshafeey, Mohamed A Elsherbiny, Mohsen M FathallahClinical Therapeutics|August 22, 2009
Shifting the paradigm toward earlier treatment of multiple sclerosis with interferon betaGiancarlo ComiClinical Therapeutics|August 22, 2009
Bioequivalence of zonisamide orally dispersible tablet and immediate-release capsule formulations: results from two open-label, randomized-sequence, single-dose, two-period, two-treatment crossover studies in healthy male volunteersRob van Maanen, Darren BentleyClinical Therapeutics|August 22, 2009
Identification of patients receiving peritoneal dialysis using health insurance claims dataAriel Berger, John Edelsberg, Gary Inglese, et al.Clinical Therapeutics|August 22, 2009
Once-monthly oral ibandronate in postmenopausal osteoporosis: translation and updated reviewMaurizio Rossini, Ombretta Viapiana, Davide Gatti, et al.Clinical Therapeutics|August 22, 2009
Bioequivalence of generic and branded subcutaneous enoxaparin: a single-dose, randomized-sequence, open-label, two-period crossover study in healthy Chinese male subjectsLimin Feng, Jianzhong Shen-Tu, Jian Liu, et al.Pageof 680